🍪 The GLP Lounge uses cookies to improve your experience, analyze traffic, and personalize content. By continuing to use this site, you agree to our Cookie Policy.
Evidence-based GLP-1 & peptide discussion since 2023
ForumsPublic SquareHas anyone dealt with adolescent obesity: aap guidelines and glp-1 use in minors? Page 3

Has anyone dealt with adolescent obesity: aap guidelines and glp-1 use in minors?

josh_phd_bmore Tue, Jan 9, 2024 at 10:52 AM 12 replies 2,199 viewsPage 3 of 3
mike_nyc
VIP Member
5,678
21,345
Nov 2023
New York
Online
Jan 10, 2024 at 1:38 PM#11
Dr.EndoEP said:
Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals.

Correct, and worth adding that it is reversible. Nothing being described here is a one-way door, which changes how cautious it is reasonable to be.

That is the short version; the long version is somebody else's post.

17 17maya_sedona, stefan_berlin, Dr.EM_Chicago and 14 others
Reply Quote Save Share Report
SandraNC_45
Member
312
1,345
Sep 2024
Charlotte, NC
Jan 10, 2024 at 4:15 PM#12
FitDadDave said:
CarlaRPh_TPA said: ...regarding the trial evidence...

Saving this. It is the first explanation that did not require me to already understand it. I will report back once I have actually tried it.

16 16james_edin, FranDenver, Dr.BariatricHTX and 13 others
Reply Quote Save Share Report
jennifer_SEA
Member
234
890
Nov 2024
Seattle, WA
Jan 10, 2024 at 6:52 PM#13
Dr.EndoEP said:
Bayesian meta-analysis perspective on the trial evidence: traditional frequentist meta-analyses report point estimates and confidence intervals.

Pushing back on Dr.EndoEP here. I think the framing smuggles in the conclusion. Ask it the other way round and the obvious answer reverses, which usually means the question is doing the work.

Last edited: Jan 11, 2024 at 12:52 AM
15 15matt_MKE, Dr.ReproEndo, lucas_SP_BR and 12 others
Reply Quote Save Share Report

PeptideMeter — Independent Peptide Analytics

Community-driven peptide testing and vendor rating platform. Transparent results. Unbiased analysis. Trusted by thousands.

View Results
TrialTracker_MD
Senior Member
2,345
15,678
Jan 2024
Maryland
Jan 10, 2024 at 9:29 PM#14

One concrete data point for the thread. Worth stating the units and the reference range whenever you post a number here. A large fraction of the apparent disagreement in these threads is two people using different units and both being right.

14 14Dr.PulmRoch, maya_sedona, stefan_berlin and 11 others
Reply Quote Save Share Report
Admin
Administrator
2,456
9,812
Oct 2023
Online
Jan 11, 2024 at 12:06 AM#15

Moderator note: leaving this open. It is being argued well and the disagreement is the useful part.

13 13PeptideSynthNJ, Dr.KarenChen, Dr.NateNeph and 10 others
Reply Quote Save Share Report

Similar Threads

SELECT trial 4-year follow-up data released — sustained MACE reduction16 replies
GLP-1 receptor agonists and thyroid C-cell concerns — evidence review19 replies
Is there a ceiling effect for GLP-1-mediated weight loss?20 replies
Comparative pharmacokinetics: semaglutide vs tirzepatide vs retatrutide6 replies
My 18-month semaglutide journey — comprehensive data log20 replies
ForumsNewTrendingMembersAccount

Log In

Forgot password?
No account? Register